MedTrace Logo

Cornell University-Micronutrient Initiative Calcium Supplementation Study

NCT02238704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1032

Last updated 2016-07-27

No results posted yet for this study

Summary

The World Health Organization (WHO) now recommends prenatal calcium supplementation for prevention of preeclampsia in populations with inadequate dietary intake. This study seeks to compare the effect of two dosing strategies on the amount of supplement ingested by pregnant women and adherence to related recommendations.

Conditions

Interventions

DIETARY_SUPPLEMENT

Regimen A calcium and iron/folic acid

Comparison of recommended administration schedule for calcium and iron/folic acid supplements in pregnant women

DIETARY_SUPPLEMENT

Regimen B calcium and iron/folic acid

Comparison of recommended administration schedule for calcium and iron/folic acid supplements in pregnant women

Sponsors & Collaborators

  • Kenya Ministry of Health

    collaborator OTHER_GOV

  • University of Nairobi

    collaborator OTHER

  • Micronutrient Initiative

    collaborator OTHER

  • Cornell University

    lead OTHER

Principal Investigators

  • Katherine Dickin, PhD · Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238704 on ClinicalTrials.gov